Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. Behind this construction is Jeff Legos, Ph.D., who became the firm’s chief oncology officer last year following a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results